5min chapter

UK Investor Magazine cover image

GlaxoSmithKline, UK house prices, and Sovereign Metals with Alan Green

UK Investor Magazine

CHAPTER

Ador, the Company's Flagship Project, Has Grown Revenues by Ten %

Ador is developing molecular bi biology solutions to provide rapid testing for bacterial, viral or fungal infections using a dna and arinasa sampling. Networking siber division revenues fell following the sale of n g soft, but it's realized a capital gain of 13 million dollars from that. The company expects to deliver revenues and abida substantially ahead of market expectations, with growth of over forty % year on year. And i think you'll see in the coming weeks, the term the company is going to er. It will be a porting to the market.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode